课题基金 / 基金详情

Characterization of Stat6 protease and Stat5 protease

Characterization of Stat6 protease and Stat5 protease
Stat6 蛋白酶和 Stat5 蛋白酶的表征
批准号:
15591046
负责人:
NAKAJIMA Hiroshi
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

NAKAJIMA Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Accumulating evidence suggests that STAT-mediated signaling plays critical roles in cell differentiation and/or cell expansion and that thus, STAT-mediated signaling is regulated strictly by many mechanisms. In murine mast cells, when Stat6 is activated by IL-4 and translocated to the nucleus, Stat6 is cleaved by a nucleus-associated protease (namely Stat6-protease). Similarly, the activated Stat5 is cleaved by a protease (Stat5-protease) in the nucleus of myeloid progenitors. These STAT proteases cleave the corresponding STAT proteins at the carboxyl-terminus and the resultant STAT proteins function as dominant negative molecules. Functionally, Stat6-protease protects mast cells from Stat6-dependent growth inhibition while Stat5-protease maintains the immature state of myeloid progenitors. These findings indicate that the proteolytic processing of STAT proteins by the nucleus-associated protease functions as a lineage-specific negative-regulator of STAT-mediated signaling.In the present study, we further characterized these Stat proteases. Interestingly, the activity of Stat6 protease but not of Stat5 protease was inhibited by ONO-5046, a narrow-spectrum elastase inhibitor that inhibits the activity of neutrophil elastase(NE) and proteinase 3(PR3) but not of cathepsin G. Although both NE and PR3 were expressed in bone marrow-derived mast cells and were capable to cleave Stat6 in vitro, our results demonstrated that NE and PR3 differed from mast cell-specific Stat6 protease. These results suggest that Stat6 protease may be an NE-like protease that is exclusively expressed in the nucleus of mast cells.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.bbrc.2003.08.067
发表时间: 2003-10
期刊: Biochemical and biophysical research communications
影响因子: 3.1
作者: [Kotaro Suzuki;H. Nakajima;K. Ikeda;T. Tamachi;T. Hiwasa;Y. Saito;I. Iwamoto]
通讯作者: Kotaro Suzuki;H. Nakajima;K. Ikeda;T. Tamachi;T. Hiwasa;Y. Saito;I. Iwamoto
Stat5a inhibits IL-12-induced cell differentiation through the induction of SOCS3 expression.
Stat5a 通过诱导 SOCS3 表达来抑制 IL-12 诱导的细胞分化。
DOI: --
发表时间: 2005
期刊: J.Immunol (In press)
影响因子: --
作者: [Nakajima H, Takatori H, Kubo M, Yoshimura A, Iwamoto I.]
通讯作者: Iwamoto I.
Ikeda K, Nakajima H, Suzuki K, Saito Y, Iwamoto I et al.: "Mast cells produce Interleukin-25 upon FcεRI-mediated activation"Blood. 101. 3594-3596 (2003)
Ikeda K、Nakajima H、Suzuki K、Saito Y、Iwamoto I 等人:“肥大细胞在 FcεRI 介导的激活后产生白细胞介素 25”Blood.101. 3594-3596 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Indispensable role of Stat5a in Stat6-independent Th2 cell differentiation and allergic airway inflammation.
Stat5a 在不依赖 Stat6 的 Th2 细胞分化和过敏性气道炎症中发挥着不可或缺的作用。
DOI: --
发表时间: 2005
期刊: Journal of Immunology 174
影响因子: --
作者: [Takatori H, Nakajima H, Hirose K, Kagami S-i, Iwamoto I]
通讯作者: Iwamoto I
14
    The Criminal Procedure and the Person with Mental Disorders or Intellectual Disabilities
    • 批准号:
      15K03178
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.08万
    • 财政年份:
      2015
    • 负责人:
      NAKAJIMA Hiroshi
    • 依托单位:
    Construction of a porphyrin capsule applicable to a photodynamic therapy
    • 批准号:
      25620130
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.58万
    • 财政年份:
      2013
    • 负责人:
      NAKAJIMA Hiroshi
    • 依托单位:
    Reduction of memory Th2 cell pool for the treatment of allergic diseases
    • 批准号:
      23659496
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      NAKAJIMA Hiroshi
    • 依托单位:
    Development of Mixed Analog ASIC for High-Speed Low-Noise Signal Processing of X-ray CCDs
    • 批准号:
      22740122
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.83万
    • 财政年份:
      2010
    • 负责人:
      NAKAJIMA Hiroshi
    • 依托单位:
    国内基金
    海外基金
    铜砭刮痧调控JAK1/STAT5通路减轻慢性湿疹(血虚风燥型)炎症反应的机制研究
    IFN- α 通过SOCS3/JAK2/STAT5通路调控 H3N2流感病毒引起的鼻黏膜嗜酸性粒细 胞浸润性炎症的分子机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2025
    • 负责人:
      洪海裕
    • 依托单位:
    STAT5的棕榈酰化修饰调控Treg细胞分化在肾移植术后ABMR中的作用机制研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      --
    • 依托单位:
    间充质干细胞来源抗菌肽LL37调控CD4+T细胞JAK/STAT5/Foxp3通路保护早产儿肺血管炎性损伤的作用及机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      任竹潇
    • 依托单位: